No Data
No Data
Express News | State Council Meeting: The role of Intermediary Institutions in Capital Markets as "gatekeepers" should be well utilized to prevent improper bundling of interests between Intermediary Institutions and issuers.
Express News | Guolian Securities: Maintains the "Buy" rating for Xiaopeng Autos-W, with the layout of SUVs potentially becoming a key to subsequent sales growth.
The China Securities Regulatory Commission: Strengthening the comprehensive and multi-dimensional accountability for securities violations and holding violators liable for civil damages.
According to reports from the mainland's Securities Times, regarding the Nanjing Intermediate Court and Shenzhen Intermediate Court's application of ordinary representative litigation procedures for the cases of Jin Tong Ling Technology Group (300091.SZ) and Meishang Ecology Securities for false statement liability disputes, the Investor Service Center stated on December 20 that it is closely monitoring the litigation progress of the Meishang Ecology case and the Jin Tong Ling case. It will accept special authorization from more than 50 investors to apply to participate in the litigation and convert to the special representative litigation procedure. A responsible person from the relevant department of the CSRC pointed out that the CSRC supports the advancement of the special representative litigation work for these two cases in accordance with the law and will continue to work with relevant parties to intensify efforts.
With the wave of Brokerage mergers and acquisitions approaching, how will it shake up the market?
Today, the A-shares Brokerage Sector displayed mixed performance. By the close of the afternoon, CITIC SEC, China Merchants, and HTSC saw slight increases, while East Money Information, China International Capital Corporation, and Orient experienced slight declines, with Guolian dropping by 2.56%. In terms of news, Guolian's acquisition of Minsheng Securities has successfully passed the review. According to the Shanghai Stock Exchange, on December 17, Guolian's issuance of A-shares to purchase 99.26% of Minsheng Securities shares and raise matching funds has been approved for review, marking the first merger and acquisition case approved in the securities industry since the new 'National No. 9' policy. Next, it will await registration submission. Mergers and acquisitions often have a significant impact on the stock prices of listed companies, like Hainan Shuangcheng Pharmaceuticals.
Guolian Securities (601456): The merger and acquisition matter has been smoothly approved, and a new starting point is about to embark.
Report introduction: The company's merger with Minsheng Securities has successfully passed the review and will be formally implemented after registration and approval by the China Securities Regulatory Commission. As the first Brokerage merger in recent years that is about to be realized, the effects of the "Guolian + Minsheng" merger are worth paying attention to. Investment highlights: Investment advice:
China Securities Clearing Corporation: Starting next year, the handling fee for dividends on A-shares in the Shanghai and Shenzhen markets will be halved.
In order to increase the incentive for listed companies to distribute Dividends and enhance investor returns, the China Securities Registration and Clearing Company has issued a notice stating that starting next year, a preferential policy will be implemented for the A-share Dividend distribution handling fee in the Shanghai and Shenzhen markets, reducing the fee by half. Specifically, the handling fee will be charged at 0.5% of the total amount of cash distributed, and for amounts exceeding 1.5 million yuan, the excess will be exempt from the fee.